Skip to contentI
iBio, Inc.
I
IBIOiBio, Inc. Q1 2017 · 10-Q
Revenue$135.00K$135.00K−15.6% vs Q1 2016 Net Income-$3.06M-$3.06MN/M vs Q1 2016 EPS Diluted-$0.03-$0.03N/M vs Q1 2016 Operating Income-$3,154,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
iBio, Inc. · CIK 1420720 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,673,000N/M Margins · derivedOperating margin-2336.3%−1203.2 pt vs Q1 2016
Net margin-2267.4%−1139.3 pt vs Q1 2016
ended Sep 30, 2016 · filed Nov 18, 2016 · 49 d after period end